APRE - Aprea Therapeutics EPS misses by $0.24 March, 26 2020 08:04 AM Aprea Therapeutics Inc. Aprea Therapeutics (NASDAQ:APRE): Q4 GAAP EPS of -$0.64 misses by $0.24.Cash and cash equivalents of $130M.Press ReleaseMore news on: Aprea Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,